Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary Arteries: A Network Meta-Analysis.

[1]  A. Kastrati,et al.  Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis , 2015, The Lancet.

[2]  Nirmal Singh,et al.  Composite outcomes in 2.25-mm drug eluting stents: a systematic review. , 2015, Cardiovascular revascularization medicine : including molecular interventions.

[3]  A. Colombo,et al.  A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. , 2015, International journal of cardiology.

[4]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  P. Serruys,et al.  Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials , 2013, The Lancet.

[6]  M. Joner,et al.  Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography , 2013, Heart.

[7]  Panagiota Spyridonos,et al.  Graphical Tools for Network Meta-Analysis in STATA , 2013, PloS one.

[8]  Andrea Cipriani,et al.  Conceptual and Technical Challenges in Network Meta-analysis , 2013, Annals of Internal Medicine.

[9]  I. Barbash,et al.  Comparison of long-term outcomes between everolimus-eluting and sirolimus-eluting stents in small vessels. , 2013, The American journal of cardiology.

[10]  A. Kastrati,et al.  Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial , 2013, The Lancet.

[11]  A. Colombo,et al.  A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. , 2012, Journal of the American College of Cardiology.

[12]  Dan Jackson,et al.  Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression‡ , 2012, Research synthesis methods.

[13]  G. Stone,et al.  Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trials. , 2011, Journal of interventional cardiology.

[14]  Ian R. White,et al.  Multivariate Random-effects Meta-regression: Updates to Mvmeta , 2011 .

[15]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[16]  S. Rathore.  Small coronary vessel angioplasty: outcomes and technical considerations , 2010, Vascular health and risk management.

[17]  B. Cortese,et al.  Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study , 2010, Heart.

[18]  F. Eberli,et al.  Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. , 2009, JACC. Cardiovascular interventions.

[19]  D. Ardissino,et al.  Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study. , 2009, European heart journal.

[20]  Ian R. White,et al.  Multivariate Random-effects Meta-analysis , 2009 .

[21]  David J Spiegelhalter,et al.  A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.

[22]  D. Baim,et al.  Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. , 2008, JACC. Cardiovascular interventions.

[23]  Georgia Salanti,et al.  Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.

[24]  A. Kastrati,et al.  Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. , 2006, European heart journal.

[25]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[26]  I. Palacios,et al.  Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results. , 2005, The American journal of medicine.

[27]  I. Palacios,et al.  Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results. , 2005, American heart journal.

[28]  P. Serruys,et al.  Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. , 2005, European heart journal.

[29]  E. Bramucci,et al.  Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. , 2004, JAMA.

[30]  J. Hausleiter,et al.  A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries , 2004, Journal of internal medicine.

[31]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[32]  K. Nasu,et al.  Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: Final results of COMPASS , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[33]  C. Visser,et al.  Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries. , 2004, The American journal of cardiology.

[34]  J. Popma,et al.  The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). , 2004, Journal of the American College of Cardiology.

[35]  William Wijns,et al.  Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.

[36]  O. Amoudi,et al.  Effectiveness of stents in small coronary arteries. , 2003, The American journal of cardiology.

[37]  C. Di Mario,et al.  In-stent restenosis in small coronary arteries: impact of strut thickness. , 2002, Journal of the American College of Cardiology.

[38]  J. Kjekshus,et al.  Stenting in small coronary arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent. , 2001, Journal of the American College of Cardiology.

[39]  S Doucet,et al.  Stent Placement to Prevent Restenosis After Angioplasty in Small Coronary Arteries , 2001, Circulation.

[40]  P. Guyon,et al.  Stent Placement Compared With Balloon Angioplasty for Small Coronary Arteries: In-Hospital and 6-Month Clinical and Angiographic Results , 2001, Circulation.

[41]  A. Kastrati,et al.  A Randomized Trial Comparing Stenting With Balloon Angioplasty in Small Vessels in Patients With Symptomatic Coronary Artery Disease , 2000 .

[42]  Seung‐Jung Park,et al.  Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. , 2000, European heart journal.

[43]  C. Di Mario,et al.  Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. , 1998, Journal of the American College of Cardiology.

[44]  M. Hadamitzky,et al.  Vessel size and long-term outcome after coronary stent placement. , 1998, Circulation.

[45]  J. Moses,et al.  Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators. , 1998, Journal of the American College of Cardiology.

[46]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[47]  J. Birkmeyer,et al.  Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. , 1996, Circulation.

[48]  M. Joner,et al.  Drug-coated balloon therapy in coronary and peripheral artery disease , 2014, Nature Reviews Cardiology.

[49]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[50]  A. Kastrati,et al.  A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. , 2000, Circulation.